Skip to main navigation

About Us
Our Science
Our Portfolio
Investors & Media
Careers
- Join Us
- Current Openings
Contact

News Releases

Year

Sep 26, 2022

Omega Therapeutics to Participate in Two Upcoming Investor Conferences

Sep 06, 2022

Omega Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Sep 01, 2022

Omega Therapeutics Announces Appointment of Rainer Boehm to its Board of Directors

Aug 04, 2022

Omega Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress

Aug 03, 2022

Omega Therapeutics to Participate in the 2022 Wedbush PacGrow Healthcare Conference

Jul 14, 2022

Omega Therapeutics Announces FDA Clearance of IND Application for OTX-2002, First Omega Epigenomic Controller, for MYC Driven Hepatocellular Carcinoma

Jun 30, 2022

Omega Therapeutics Presents New Preclinical Data Supporting the First Epigenomic Controller, OTX-2002, as a Potential Therapeutic Approach in Hepatocellular Carcinoma at the ESMO 2022 World Congress on Gastrointestinal Cancer

Jun 23, 2022

Omega Therapeutics to Present New Preclinical Data for the First Epigenomic Controller, OTX-2002, for Hepatocellular Carcinoma at the European Society of Medical Oncology's 2022 World Congress on Gastrointestinal Cancer

Jun 15, 2022

Omega Therapeutics Announces Submission of Investigational New Drug Application for OTX-2002, an Omega Epigenomic Controller, for MYC Driven Hepatocellular Carcinoma

Jun 02, 2022

Omega Therapeutics to Participate in the Jefferies Healthcare Conference and Goldman Sachs 43rd Annual Global Healthcare Conference in June 2022

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 18

Site - Nav - Investors & Media

Corporate Profile
News & Events
- News Releases
- Events & Presentations
Stock Information
Corporate Governance
Financials & Filings
- SEC Filings
Investor Resources

Presentation

Omega Therapeutics Corporate Overview cover 2022

Corporate Presentation – September 2022 7.3 MB

Investor & Media Contact

Argot Partners
212-600-1902
ArgotOmega@argotpartners.com

Site - Investor Tools

Print Page

Email Alerts

RSS Feeds

Contact IR

Search

Home
About Us
Our Science
Our Portfolio
Investors & Media
Careers
Contact Us

20 Acorn Park Drive
Cambridge, MA 02140

contact@omegatherapeutics.com

© Omega Therapeutics, Inc. 2022 All Rights Reserved.
All other trademarks referenced herein are properties of their respective owners.

Terms of use

Privacy Policy